Market snapshot
Monday's trading session produced a mix of rallies and sell-offs across market-cap ranges. Chip-related names featured prominently among the day’s advances, while several household and smaller-cap companies posted notable declines. Below are the principal movers grouped by market-cap band and including explanatory notes where provided.
Mega-Cap Movers ($200B+ Market Cap)
- Arm (ARM): -8.04%
- Applied Materials Inc (AMAT): -3.58%
- Advanced Micro Devices (AMD): -3.69%
- Lam Research Corp (LRCX): -3.35%
- KLA-Tencor Corp (KLAC): -2.8%
- Texas Instruments (TXN): -3.09%
- Arista Networks (ANET): -2.74%
- GE Vernova LLC (GEV): -2.44% - BNP Paribas Exane downgraded the stock to neutral (note: downgrade provided in original list)
- Micron Tech (MU): +4.38% - Melius initiated coverage with a buy rating citing AI memory demand (note: initiation detail provided in original list)
- Nvidia Corp (NVDA): +3.22%
Large-Cap Stock Movers ($10B-$200B Market Cap)
- Domino's Pizza Inc (DPZ): -9.31%
- Rambus Inc (RMBS): -9.18%
- Applied Optoelectronics (AAOI): -8.65%
- Astera Labs (ALAB): -8.48%
- Semtech Corp (SMTC): -8.16%
- Credo Technology Holding (CRDO): -7.99%
- FormFactor (FORM): -7.46%
- Fortress Value Acquisition Corp (MP): +6.72%
- Regencell Bioscience Holdings (RGC): +7.31%
- SanDisk Corp-Exch (SNDK): +7.18%
Mid-Cap Stock Movers ($2B-$10B Market Cap)
- POET Technologies NAQ (POET): -47.48% - Poet Technologies lost orders after Marvell canceled a purchase (note: cancellation detail provided in original list)
- MaxLinear Inc (MXL): -13.78%
- Willdan Group (WLDN): -13.77%
- CF Acquisition Corp VI (RUMBW): +12.84%
- Cleveland-Cliffs (CLF): +9.78%
- Rumble (RUM): +8.97%
- Veradermics Inc (MANE): +34.11% - Veradermics planned to present Phase 2/3 hair loss trial results Monday (note: presentation detail provided in original list)
- Organon Co (OGN): +17.14%
- ARCA biopharma (ORKA): +15.23% - ORKA-001 achieved 63.5% complete skin clearance in trial (note: trial result provided in original list)
- X Energy Inc (XE): +15.24%
Small-Cap Stock Movers ($300M-$2B Market Cap)
- Compass Therapeutics, NAQ (CMPX): -65.41% - Compass Therapeutics’ tovecimig meets PFS endpoint in bile duct cancer (note: outcome and move listed together in the original item)
- Real Brokerage USA (REAX): -27.05%
- Aspirational Consumer Lifestyle (UP): -19.07%
- AAOX (AAOX): -17.07%
- Velo3D (VELO): -16.76%
- Ampliphi Biosciences (ARMP): -15.56% - Armata Pharmaceuticals adds Pfizer executive to board (note: board appointment detail listed alongside ticker in the original item)
- LightPath Technologies (LPTH): -15.41%
- Absci (ABSI): +20.56%
- SNXX (SNXX): +14.17%
Takeaways
The session featured concentrated moves driven by analyst actions, corporate orders and trial news cited alongside individual tickers. The lists above include the percent moves published for each company and the specific notes that were supplied in the original listing.
Note: The breakdown lists companies by market-cap classification and reports the percentage moves and associated details exactly as provided in the market highlights for the day.